Bienvenu AL - Search Results

1

Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants.

Bienvenu AL, Pradat P, Matusik E, Piriou V, Rimmelé T, Parant F, Tod M, Leboucher G, Goutelle S; Antifungal study group. Bienvenu AL, et al. Infect Dis Now. 2023 Mar;53(2):104630. doi: 10.1016/j.idnow.2022.10.002. Epub 2022 Oct 31. Infect Dis Now. 2023. PMID: 36328312

2

Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis.

Parize P, Billaud S, Bienvenu AL, Bourdy S, le Pogam MA, Reix P, Picot S, Robert R, Lortholary O, Bouchara JP, Durieu I. Parize P, et al. Among authors: bienvenu al. J Cyst Fibros. 2014 Dec;13(6):667-73. doi: 10.1016/j.jcf.2014.01.011. Epub 2014 Feb 12. J Cyst Fibros. 2014. PMID: 24530191 Free article.

3

Isavuconazole off-label use as an empirical treatment of invasive fungal infections.

Bienvenu AL, Gasser C, Ducastelle-Lepretre S, Bleyzac N, Piriou V, Durieu I, Roux S, Millet A, Ghesquières H, Leboucher G, Goutelle S. Bienvenu AL, et al. Ann Pharm Fr. 2024 Oct 23:S0003-4509(24)00159-7. doi: 10.1016/j.pharma.2024.10.005. Online ahead of print. Ann Pharm Fr. 2024. PMID: 39454853

4

Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for Candida infections.

Matusik E, Vassal O, Conrad A, Ferry T, Millet A, Dupont D, Grandjean L, Guitton J, Roux S, Bienvenu A-L, Bohé J, Friggeri A, Goutelle S. Matusik E, et al. Antimicrob Agents Chemother. 2024 Sep 26:e0099124. doi: 10.1128/aac.00991-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39324800

5

[Can environmental impact be considered as a dimension of the proper use of medicines? From the 5th Forum of the Association for the Proper Use of Medicines].

Hamon PA, Bienvenu AL, Gimenes N, Besançon L, Thierry JP, Augé-Caumon MJ, Baseilhac E. Hamon PA, et al. Among authors: bienvenu al. Ann Pharm Fr. 2024 Nov;82(6):1008-1012. doi: 10.1016/j.pharma.2024.07.001. Epub 2024 Jul 9. Ann Pharm Fr. 2024. PMID: 38992833 French.

6

Correlation between antifungal clinical practices and a new clinical decision support system ANTIFON-CLIC® for the treatment of invasive candidiasis: a retrospective multicentre study.

Bienvenu AL, Cour M, Pavese P, Guichon C, Leray V, Chapuis C, Dureault A, Mohkam K, Gallet S, Bourget S, Kahale E, Chaabane W, Subtil F, Maucort-Boulch D, Talbot F, Dode X, Richard JC, Leboucher G. Bienvenu AL, et al. J Antimicrob Chemother. 2024 Jun 3;79(6):1407-1412. doi: 10.1093/jac/dkae118. J Antimicrob Chemother. 2024. PMID: 38656566

7

Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020).

Paccoud O, Desnos-Ollivier M, Persat F, Demar M, Boukris-Sitbon K, Bellanger AP, Bonhomme J, Bonnal C, Botterel F, Bougnoux ME, Brun S, Cassaing S, Cateau E, Chouaki T, Cornet M, Dannaoui E, Desbois-Nogard N, Durieux MF, Favennec L, Fekkar A, Gabriel F, Gangneux JP, Guitard J, Hasseine L, Huguenin A, Le Gal S, Letscher-Bru V, Mahinc C, Morio F, Nicolas M, Poirier P, Ranque S, Roosen G, Rouges C, Roux AL, Sasso M, Alanio A, Lortholary O, Lanternier F; French Mycoses Study Group. Paccoud O, et al. Clin Microbiol Infect. 2024 Jul;30(7):937-944. doi: 10.1016/j.cmi.2024.03.031. Epub 2024 Mar 29. Clin Microbiol Infect. 2024. PMID: 38556212

8

Specifically Targeting Metacaspases of Candida: A New Therapeutic Opportunity.

Bienvenu AL, Ballut L, Picot S. Bienvenu AL, et al. J Fungi (Basel). 2024 Jan 23;10(2):90. doi: 10.3390/jof10020090. J Fungi (Basel). 2024. PMID: 38392762 Free PMC article. Review.

9

Nanoparticle tracking analysis of natural hemozoin from Plasmodium parasites.

Omorou R, Delabie B, Lavoignat A, Chaker V, Bonnot G, Traore K, Bienvenu AL, Picot S. Omorou R, et al. Among authors: bienvenu al. Acta Trop. 2024 Feb;250:107105. doi: 10.1016/j.actatropica.2023.107105. Epub 2023 Dec 20. Acta Trop. 2024. PMID: 38135133 Free article.

10

ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?

Bienvenu AL, Leray V, Guichon C, Bourget S, Chapuis C, Duréault A, Pavese P, Roux S, Kahale E, Chaabane W, Subtil F, Maucort-Boulch D, Talbot F, Dode X, Ghesquières H, Leboucher G. Bienvenu AL, et al. Ann Pharm Fr. 2024 May;82(3):514-521. doi: 10.1016/j.pharma.2023.11.002. Epub 2023 Nov 22. Ann Pharm Fr. 2024. PMID: 38000506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters